FidoCure®

Winter 2018Active

FidoCure® is the leader in Precision Medicine for Canine Oncology.

Save

FidoCure®

Winter 2018Active

FidoCure® is the leader in Precision Medicine for Canine Oncology.

Save

Company details

Cancer is a genetic disease. We know this from decades of human and veterinary cancer research. Precision medicine and targeted therapies are successfully used to treat humans with cancer. At FidoCure®, we bring this approach to the world of veterinary medicine.

FidoCure® empowers veterinarians to offer genetic sequencing and targeted therapies to treat dogs with cancer. We are committed to expanding the veterinary oncology toolbox for both diagnostics and therapeutics.

Our veterinary partners have treated thousands of dogs over the past 30 years and work closely with the growing FidoCure® network of over 143 clinics and 180 forward-thinking veterinary oncologists throughout the US.

Together, we can combat canine cancer!

Location

San Francisco, CA, USA; Palo Alto, CA, USA; Remote

Founded

Unknown

Request the FidoCure® report.

FidoCure® has no report yet. Sign in with your email to request one.